Downregulation of canonical Wnt signaling in hippocampus of SAMP8 mice

Neurobiology of Aging

Volumn 36, Issue 2, 2015, Pages 720-729

  Bayod, Sergi ^a,b   Felice, Paolo ^a,b   Andrés, Pol ^a,b   Rosa, Paolo ^a,b   Camins, Antoni ^a,b   Pallàs, Mercè ^a,b   Canudas, Anna Maria ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Aging; Alzheimer's disease; DKK 1; Hippocampus; SAMP8; Wnt; catenin

Indexed keywords

DICKKOPF 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN BAX; PROTEIN BCL 2; SERINE; TAU PROTEIN; THREONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BCL 2 GENE; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DENTATE GYRUS; DOWN REGULATION; ENZYME ACTIVATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; WNT SIGNALING PATHWAY; AGING; ALZHEIMER DISEASE; ANIMAL; COGNITION; DISEASE MODEL; GENETICS; INBRED MOUSE STRAIN; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

AGING; ALZHEIMER DISEASE; ANIMALS; COGNITION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HIPPOCAMPUS; MALE; MICE, INBRED STRAINS; NERVE DEGENERATION; NEURONS; WNT SIGNALING PATHWAY;

EID: 84922819712     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.09.017     Document Type: Article

References (61)

1. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. beta-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997, 16:3797-3804.
2. Álvarez-García O., Vega-Naredo I., Sierra V., Caballero B., Tomás-Zapico C., Camins A., García J.J., Pallàs M., Coto-Montes A. Elevated oxidative stress in the brain of senescence-accelerated mice at 5 months of age. Biogerontology 2006, 7:43-52.
3. Bayod S., Menella I., Sanchez-Roige S., Lalanza J.F., Escorihuela R.M., Camins A., Pallàs M., Canudas A.M. Wnt pathway regulation by long-term moderate exercise in rat hippocampus. Brain Res. 2014, 1543:38-48.
4. Berwick D.C., Harvey K. The regulation and deregulation of Wnt signaling by PARK genes in health and disease. J.Mol. Cell Biol 2014, 6:3-12.
5. Canudas A.M., Gutierrez-Cuesta J., Rodríguez M.I., Acuña-Castroviejo D., Sureda F.X., Camins A., Pallàs M. Hyperphosphorylation of microtubule associated protein tau in senescence-accelerated mouse (SAM). Mech. Ageing Dev. 2005, 126:1300-1304.
6. Caricasole A., Copani A., Caraci F., Aronica E., Rozemuller A.J., Caruso A., Storto M., Gaviraghi G., Terstappen G.C., Nicoletti F. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J.Neurosci. 2004, 24:6021-6027.
7. Ciani L., Krylova O., Smalley M.J., Dale T.C., Salinas P.C. Adivergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubules. J.Cell Biol 2004, 164:243-253.
8. Clavaguera F., Bolmont T., Crowther R.A., Abramowski D., Frank S., Probst A., Fraser G., Stalder A.K., Beibel M., Staufenbiel M., Jucker M., Goedert M., Tolnay M. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol 2009, 11:909-913.
9. Clevers H., Nusse R. Wnt/β-catenin signaling and disease. Cell 2012, 149:1192-1205.
10. del Valle J., Bayod S., Camins A., Beas-Zárate C., Velázquez-Zamora D.A., González-Burgos I., Pallàs M. Dendritic spine abnormalities in hippocampal CA1 pyramidal neurons underlying memory deficits in the SAMP8 mouse model of Alzheimer's disease. J.Alzheimers Dis. 2012, 32:233-240.
11. Del Valle J., Duran-Vilaregut J., Manich G., Casadesús G., Smith M.A., Camins A., Pallàs M., Pelegrí C., Vilaplana J. Early amyloid accumulation in the hippocampus of SAMP8 mice. J.Alzheimers Dis. 2010, 19:1303-1315.
12. Dickins E.M., Salinas P.C. Wnts in action: from synapse formation to synaptic maintenance. Front. Cell. Neurosci 2013, 7:162.
13. Doble B.W., Patel S., Wood G.A., Kockeritz L.K., Woodgett J.R. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 2007, 12:957-971.
14. Fortress A.M., Schram S.L., Tuscher J.J., Frick K.M. Canonical Wnt signaling is necessary for object recognition memory consolidation. J.Neurosci. 2013, 33:12619-12626.
15. Fuentealba R.A., Farias G., Scheu J., Bronfman M., Marzolo M.P., Inestrosa N.C. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease. Brain Res. Brain Res. Rev. 2004, 47:275-289.
16. Gan X.Q., Wang J.Y., Xi Y., Wu Z.L., Li Y.P., Li L. Nuclear Dvl, c-Jun, beta catenin, and TCF form a complex leading to stabilization of beta catenin-TCF interaction. J.Cell Biol 2008, 180:1087-1100.
17. Gang B., Yue C., Han N., Xue H., Li B., Sun L., Li X., Zhao Q. Limited hippocampal neurogenesis in SAMP8 mouse model of Alzheimer's disease. Brain Res. 2011, 1389:183-193.
18. Gao C., Chen Y.G. Dishevelled: the hub of Wnt signaling. Cell. Signal 2010, 22:717-727.
19. Giralt A., Saavedra A., Carretón O., Arumí H., Tyebji S., Alberch J., Pérez Navarro E. PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model. Hippocampus 2013, 23:684-695.
20. Goedert M., Jakes R., Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 1995, 189:167-169.
21. Gutierrez-Cuesta J., Tajes M., Jiménez A., Coto-Montes A., Camins A., Pallàs M. Evaluation of potential pro-survival pathways regulated by melatonin in a murine senescence model. J.Pineal Res. 2008, 45:497-505.
22. Hanger D.P., Anderton B.H., Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 2009, 15:112-119.
23. Hung C.W., Chen Y.C., Hsieh W.L., Chiou S.H., Kao C.L. Ageing and neurodegenerative diseases. Ageing Res. Rev. 2010, 9(Suppl 1):S36-S46.
24. Hussain M., Rao M., Humphries A.E., Hong J.A., Liu F., Yang M., Caragacianu D., Schrump D.S. Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells. Cancer Res. 2009, 69:3570-3578.
25. Inestrosa N.C., Montecinos-Oliva C., Fuenzalida M. Wnt signaling: role in Alzheimer disease and schizophrenia. J.Neuroimmune Pharmacol. 2012, 7:788-807.
26. Inestrosa N.C., Varela-Nallar L. Wnt signaling in the nervous system and in Alzheimer's disease. J.Mol. Cell Biol 2014, 6:64-74.
27. Itoh K., Brott B.K., Bae G.U., Ratcliffe M.J., Sokol S.Y. Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling. J.Biol. 2005, 4:3.
28. Jope R.S., Yuskaitis C.J., Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 2007, 32:577-595.
29. Kempermann G., Jessberger S., Steiner B., Kronenberg G. Milestones of neuronal development in the adult hippocampus. Trends Neurosci. 2004, 27:447-452.
30. Kim H., Won S., Hwang D.Y., Lee J.S., Kim M., Kim R., Kim W., Cha B., Kim T., Kim D., Costantini F., Jho E.H. Downregulation of Wnt/β-catenin signaling causes degeneration of hippocampal neurons invivo. Neurobiol. Aging 2011, 32:2316.e1-2316.e15.
31. Li G., Cheng H., Zhang X., Shang X., Xie H., Zhang X., Yu J., Han J. Hippocampal neuron loss is correlated with cognitive deficits in SAMP8 mice. Neurol. Sci. 2013, 34:963-969.
32. Li V.S., Ng S.S., Boersema P.J., Low T.Y., Karthaus W.R., Gerlach J.P., Mohammed S., Heck A.J., Maurice M.M., Mahmoudi T., Clevers H. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell 2012, 149:1245-1256.
33. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
34. Liu G.S., Zhang Z.S., Yang B., He W. Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice. Life Sci. 2012, 91:872-877.
35. Maher M.T., Mo R., Flozak A.S., Peled O.N., Gottardi C.J. Beta-catenin phosphorylated at serine 45 is spatially uncoupled from beta-catenin phosphorylated in the GSK3 domain: implications for signaling. PLoS One 2010, 5:e10184.
36. Maiese K., Li F., Chong Z.Z., Shang Y.C. The Wnt signaling pathway: aging gracefully as a protectionist?. Pharmacol. Ther. 2008, 118:58-81.
37. Manich G., Mercader C., del Valle J., Duran-Vilaregut J., Camins A., Pallàs M., Vilaplana J., Pelegrí C. Characterization of amyloid-β granules in the hippocampus of SAMP8 mice. J.Alzheimers Dis. 2011, 25:535-546.
38. Meffre D., Grenier J., Bernard S., Courtin F., Dudev T., Shackleford G., Jafarian-Tehrani M., Massaad C. Wnt and lithium: a common destiny in the therapy of nervous system pathologies?. Cell. Mol. Life Sci 2014, 71:1123-1148.
39. Mercado-Gómez O., Hernández-Fonseca K., Villavicencio-Queijeiro A., Massieu L., Chimal-Monroy J., Arias C. Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation. Neurochem. Res. 2008, 33:1599-1609.
40. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., Burns M., Krishnamurthy P., Wen Y., Bhat R., Lewis J., Dickson D., Duff K. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration invivo. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:6990-6995.
41. Okerlund N.D., Cheyette B.N. Synaptic Wnt signaling-a contributor to major psychiatric disorders?. J.Neurodev. Disord. 2011, 3:162-174.
42. Pallas M., Camins A., Smith M.A., Perry G., Lee H.G., Casadesus G. From aging to Alzheimer's disease: unveiling "the switch" with the senescence accelerated mouse model (SAMP8). J.Alzheimers Dis. 2008, 15:615-624.
43. Pallàs M., Pizarro J.G., Gutierrez-Cuesta J., Crespo-Biel N., Alvira D., Tajes M., Yeste-Velasco M., Folch J., Canudas A.M., Sureda F.X., Ferrer I., Camins A. Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience 2008, 154:1388-1397.
44. Porquet D., Casadesús G., Bayod S., Vicente A., Canudas A.M., Vilaplana J., Pelegrí C., Sanfeliu C., Camins A., Pallàs M., del Valle J. Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8. Age (Dordr) 2013, 35:1851-1865.
45. Purro S.A., Dickins E.M., Salinas P.C. The secreted Wnt antagonist Dickkopf-1 is required for amyloid β-mediated synaptic loss. J.Neurosci. 2012, 32:3492-3498.
46. Rosi M.C., Luccarini I., Grossi C., Fiorentini A., Spillantini M.G., Prisco A., Scali C., Gianfriddo M., Caricasole A., Terstappen G.C., Casamenti F. Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. J.Neurochem. 2010, 112:1539-1551.
47. Rosso S.B., Inestrosa N.C. WNT signaling in neuronal maturation and synaptogenesis. Front. Cell. Neurosci 2013, 7:103.
48. Sabbagh J.J., Kinney J.W., Cummings J.L. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications. Neurobiol. Aging 2013, 34:169-183.
49. Salcedo-Tello P., Hernández-Ortega K., Arias C. Susceptibility to GSK3β induced tau phosphorylation differs between the young and aged hippocampus after Wnt signaling inhibition. J.Alzheimers Dis. 2014, 39:775-785.
50. Scali C., Caraci F., Gianfriddo M., Diodato E., Roncarati R., Pollio G., Gaviraghi G., Copani A., Nicoletti F., Terstappen G.C., Caricasole A. Inhibition of Wnt signaling, modulation of tau phosphorylation and induction of neuronal cell death by DKK1. Neurobiol. Dis. 2006, 24:254-265.
51. Seib D.R., Corsini N.S., Ellwanger K., Plaas C., Mateos A., Pitzer C., Niehrs C., Celikel T., Martin-Villalba A. Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline. Cell Stem Cell 2013, 12:204-214.
52. Semënov M.V., Tamai K., Brott B.K., Kühl M., Sokol S., He X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol. 2001, 11:951-961.
53. Shou J., Ali-Osman F., Multani A.S., Pathak S., Fedi P., Srivenugopal K.S. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene 2002, 21:878-889.
54. Sureda F.X., Gutierrez-Cuesta J., Romeu M., Mulero M., Canudas A.M., Camins A., Mallol J., Pallàs M. Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8. Exp. Gerontol. 2006, 41:360-367.
55. Tajes M., Gutierrez-Cuesta J., Folch J., Ortuño-Sahagun D., Verdaguer E., Jiménez A., Junyent F., Lau A., Camins A., Pallàs M. Neuroprotective role of intermittent fasting in senescence-accelerated mice P8 (SAMP8). Exp. Gerontol. 2010, 45:702-710.
56. Takeda T. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem. Res. 2009, 34:639-659.
57. Takeda T. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiol. Aging 1999, 20:105-110.
58. Varela-Nallar L., Inestrosa N.C. Wnt signaling in the regulation of adult hippocampal neurogenesis. Front. Cell. Neurosci 2013, 7:100.
59. Vargas J.Y., Fuenzalida M., Inestrosa N.C. Invivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer's disease model. J.Neurosci. 2014, 34:2191-2202.
60. Wang J., Shou J., Chen X. Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene 2000, 19:1843-1848.
61. Woodruff-Pak D.S. Animal models of Alzheimer's disease: therapeutic implications. J.Alzheimers Dis. 2008, 15:507-521.